- Home
- SSD vs NUVL Comparison
SSD vs NUVL Comparison
Compare SSD & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSD
- NUVL
- Stock Information
- Founded
- SSD 1956
- NUVL 2017
- Country
- SSD United States
- NUVL United States
- Employees
- SSD N/A
- NUVL 200
- Industry
- SSD Industrial Machinery/Components
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- SSD Consumer Discretionary
- NUVL Health Care
- Exchange
- SSD Nasdaq
- NUVL Nasdaq
- Market Cap
- SSD 6.7B
- NUVL 6.0B
- IPO Year
- SSD 1994
- NUVL 2021
- Fundamental
- Price
- SSD $169.66
- NUVL $83.09
- Analyst Decision
- SSD Buy
- NUVL Strong Buy
- Analyst Count
- SSD 2
- NUVL 9
- Target Price
- SSD $191.00
- NUVL $118.89
- AVG Volume (30 Days)
- SSD 285.3K
- NUVL 396.7K
- Earning Date
- SSD 10-20-2025
- NUVL 11-11-2025
- Dividend Yield
- SSD 0.68%
- NUVL N/A
- EPS Growth
- SSD 0.99
- NUVL N/A
- EPS
- SSD 7.86
- NUVL N/A
- Revenue
- SSD $2,274,532,000.00
- NUVL N/A
- Revenue This Year
- SSD $4.79
- NUVL N/A
- Revenue Next Year
- SSD $5.04
- NUVL N/A
- P/E Ratio
- SSD $21.60
- NUVL N/A
- Revenue Growth
- SSD 2.95
- NUVL N/A
- 52 Week Low
- SSD $137.35
- NUVL $55.54
- 52 Week High
- SSD $197.82
- NUVL $106.32
- Technical
- Relative Strength Index (RSI)
- SSD 34.86
- NUVL 56.32
- Support Level
- SSD $167.85
- NUVL $81.02
- Resistance Level
- SSD $171.52
- NUVL $86.34
- Average True Range (ATR)
- SSD 3.68
- NUVL 3.63
- MACD
- SSD -0.89
- NUVL 0.28
- Stochastic Oscillator
- SSD 25.82
- NUVL 66.33
About SSD Simpson Manufacturing Company Inc.
Simpson Manufacturing Co Inc is a manufacturer of wood construction products. The company offers connectors, truss plates, fastening systems, fasteners, prefabricated lateral systems, concrete construction products, adhesives, mechanical anchors, carbide drill bits, powder-actuated tools, and fiber-reinforced materials. Simpson Manufacturing markets its products to the residential, light industrial, and commercial construction markets as well as the remodeling and do-it-yourself markets. The Company is organized into three reporting segments defined by the regions namely North America, Europe, and Asia Pacific. The company generates the majority of its revenue from wood products.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.